Starboard drops out of Celgene fight as proxy firms back Bristol bid

Activist investor Starboard Value has ended its fight against Bristol-Myers Squibb’s buyout of biotechnology company Celgene after two prominent proxy advisors announced their support for the deal earlier on Friday.

Source link

Leave a Comment

Cholera cases jump to 138 in Mozambique's Beira after cyclonePortugal baby born to woman brain dead for three months